Genmab (Otc) (GMAB) has released an update.
Genmab A/S, a medical research and product company based in Copenhagen, has provided updates on its share capital and warrant issuances. The Board of Directors is authorized to issue new shares and warrants, and increase the company’s share capital with certain conditions until March 2029. These financial instruments are designed to be accessible to employees, excluding executive management, and are issued with rights similar to existing shares.
For further insights into GMAB stock, check out TipRanks’ Stock Analysis page.
